News
Nick Kharufeh's vision was restored after receiving a stem cell transplant in 2020. He now advocates for the treatment, ...
Severe visual field loss in primary angle closure glaucoma is more common in men and those who developed the disease at an earlier age.
Most studies on the combination eye drop brinzolamide and brimonidine (Symbrinza) used the drug three times daily.
Serious side effects from H2 blockers are rare. Like PPIs, they can sometimes cause low B12 levels. Headaches and agitation ...
The future of eye care holds immense promise, with innovations poised to deliver more accurate, effective, affordable, and ...
The patient information guide from Simbrinza says to use it no more than twice a day. I talked to my doctor about this last time I saw him and didn't get a satisfactory response. My eye pressure was ...
Researchers from the University of Bern analyzed over 300,000 FDA reports and found semaglutide use was linked to a higher ...
You can see something 20 feet away that others need to be 15 feet away to see. That means your vision is a little sharper ...
AI tools can help analyse retinal images to detect signs of glaucoma, and warn people about impending health risks for ...
China’s National Medical Products Administration (NMPA) has approved the marketing authorisation application of Santen ...
Seonix Bio, a leader in the development of genetic testing for glaucoma, has launched SightScore, the first commercially available clinical polygenic risk score test for primary open-angle glaucoma.
In celebration of Ophthalmology Times 50th anniversary, we asked leading experts in the field what they see as the biggest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results